medication adherence monitoring

AARDEX Group provides medication adherence monitoring for clinical trials using its MEMS® (Medication Event Monitoring System) technology. It offers connected devices, cloud-based adherence software (MEMS AS®), and analytics that give sponsors and CROs objective, real-time data on patient dosing behavior. The company has supported clinical trials across all phases and therapeutic areas for more than three decades and is headquartered in Switzerland.

Read more

adherence data analyticscloud-based softwareconnected devicessupport for decentralized, hybrid and site-based clinical trials